Yonsei Med J.  2011 Jan;52(1):1-12. 10.3349/ymj.2011.52.1.1.

Case Report and Mini Literature Review: Anesthetic Management for Severe Peripartum Cardiomyopathy Complicated with Preeclampsia Using Sufetanil in Combined Spinal Epidural Anesthesia

• Bhakta P
• Mishra P
• Bakshi A
• Langer V

• KMID: 1106430
• DOI: http://doi.org/10.3349/ymj.2011.52.1.1

Abstract

Peripartum cardiomyopathy (PPCM) is a rare entity, and anesthetic management for cesarean section of a patient with this condition can be challenging. We hereby present the anesthetic management of a patient with PPCM complicated with preeclampsia scheduled for cesarean section, along with a mini review of literature. A 24 year-old primigravida with twin gestation was admitted to our hospital with severe PPCM and preeclampsia for peripartum care, which finally required a cesarean section. Preoperative optimization was done according to the goal of managing left ventricular failure. Combined spinal epidural (CSE) anaesthesia with bupivacaine and sufentanil was used for cesarean section under optimal monitoring. The surgery was completed without event or complication. Postoperative pain relief was adequate and patient required only one epidural top up with sufentanil 6 hours after operation. To the best of our knowledge there is no report in literature of the use of sufentanil as a neuraxial opioid in the anesthetic management of cesarean section in a patient with PPCM. CSE with sufentanil may be a safer and more effective alternative in such cases.

Keyword

Peripartum cardiomyopathy; anesthetic management; combined spinal epidural; sufentanil; literature review

MeSH Terms

Anesthesia, Epidural/*methods
Anesthesia, Spinal/*methods
Cardiomyopathies/*complications
Female
Humans
Peripartum Period
Pre-Eclampsia/*surgery
Pregnancy
Sufentanil/*therapeutic use

Reference

1. Demakis JG, Rahimtoola SH. Peripartum cardiomyopathy. Circulation. 1971. 44:964–968.

2. Pearson GD, Veille JC, Rahimtoola S, Hsia J, Oakley CM, Hosenpud JD, et al. Peripartum cardiomyopathy: National Heart, Lung and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendation and review. JAMA. 2000. 283:1183–1188.

3. Hibbard JU, Lindheimer M, Lang RM. A modified definition for peripartum cardiomyopathy and prognosis based on echocardiography. Obstet Gynecol. 1999. 94:311–316.

4. Demakis JG, Rahimtoola SH, Sutton GC, Meadows WR, Szanto PB, Tobin JR, et al. Natural course of peripartum cardiomyopathy. Circulation. 1971. 44:1053–1061.

5. Bhakta P, Biswas BK, Banerjee B. Peripartum cardiomyopathy: review of the literature. Yonsei Med J. 2007. 48:731–747.

6. Mayosi BM. Contemporary trends in the epidemiology and management of cardiomyopathy and pericarditis in sub-Saharan Africa. Heart. 2007. 93:1176–1183.

7. Midei MG, DeMent SH, Feldman AM, Hutchins GM, Baughman KL. Peripartum myocarditis and cardiomyopathy. Circulation. 1990. 81:922–928.

8. Ford RF, Barton JR, O'brien JM, Hollingsworth PW. Demographics, management, and outcome of peripartum cardiomyopathy in a community hospital. Am J Obstet Gynecol. 2000. 182:1036–1038.

9. Elkayam U, Akhter MW, Singh H, Khan S, Bitar F, Hameed A, et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation. 2005. 111:2050–2055.

10. Amos AM, Jaber WA, Russell SD. Improved outcomes in peripartum cardiomyopathy with contemporary. Am Heart J. 2006. 152:509–513.

11. Rizeq MN, Rickenbacher PR, Fowler MB, Billingham ME. Incidence of myocarditis in peripartum cardiomyopathy. Am J Cardiol. 1994. 74:474–477.

12. Pryn A, Bryden F, Reeve W, Young S, Patrick A, McGrady EM. Cardiomyopathy in pregnancy and caesarean section: four case reports. Int J Obstet Anesth. 2007. 16:68–73.

13. Ntusi NB, Mayosi BM. Aetiology and risk factors of peripartum cardiomyopathy: a systemic review. Int J Cardiol. 2009. 131:168–179.

14. Modi KA, Illum S, Jariatul K, Caldito G, Reddy PC. Poor outcome of indigent patients with peripartum cardiomyopathy in the United States. Am J Obstet Gynecol. 2009. 201:171.e1–171.e5.

15. Mielniczuk LM, Williams K, Davis DR, Tang AS, Lemery R, Green MS, et al. Frequency of peripartum cardiomyopathy. Am J Cardiol. 2006. 97:1765–1768.

16. Gentry MB, Dias JK, Luis A, Patel R, Thornton J, Reed GL. African-American women have a higher risk for developing peripartum cardiomyopathy. J Am Coll Cardiol. 2010. 55:654–659.

17. Habli M, O'Brien T, Nowack E, Khoury S, Barton JR, Sibai B. Peripartum cardiomyopathy: prognostic factors for long-term maternal outcome. Am J Obstet Gynecol. 2008. 199:415.e1–415.e5.

18. Duran N, Günes H, Duran I, Biteker M, Ozkan M. Predictors of prognosis in patients with peripartum cardiomyopathy. Int J Gynaecol Obstet. 2008. 101:137–140.

19. Gleicher N, Elkayam U. Peripartum cardiomyopathy, an autoimmune manifestation of allograft rejection? Autoimmun Rev. 2009. 8:384–387.

20. Goland S, Modi K, Bitar F, Janmohamed M, Mirocha JM, Czer LS, et al. Clinical profile and predictors of complications in peripartum cardiomyopathy. J Card Fail. 2009. 15:645–650.

21. Kaufman I, Bondy R, Benjamin A. Peripartum cardiomyopathy and thromboembolism; anesthetic management and clinical course of an obese, diabetic patient. Can J Anaesth. 2003. 50:161–165.

22. Zangrillo A, Landoni G, Pappalardo F, Oppizzi M, Torri G. Different anesthesiological management in two high risk pregnant women with heart failure undergoing emergency cesarean section. Minerva Anestesiol. 2005. 71:227–236.

23. Yahagi N, Kumon K, Nakatani T, Ishikawa T, Tanigami H, Eishi K, et al. Peripartum cardiomyopathy and tachycardia followed by multiple organ failure. Anesth Analg. 1994. 79:581–582.

24. Mellor DJ, Bodenham A. Infiltration anesthesia in the management of Cesarean section in a patient with peripartum cardiomyopathy. Anaesthesia. 1996. 51:409.

25. Sliwa K, Fett J, Elkayam U. Peripartum cardiomyopathy. Lancet. 2006. 368:687–693.

26. Velickovic IA, Leicht CH. Peripartum cardiomyopathy and cesarean section: report of two cases and literature review. Arch Gynecol Obstet. 2004. 270:307–310.

27. Tibazarwa K, Sliwa K. Peripartum cardiomyopathy in Africa: challenges in diagnosis, prognosis, and therapy. Prog Cardiovasc Dis. 2010. 52:317–325.

28. Phillips SD, Warnes CA. Peripartum cardiomyopathy: Current Therapeutic Perspectives. Curr Treat Options Cardiovasc Med. 2004. 6:481–488.

29. Egan DJ, Bisanzo MC, Hutson HR. Emergency department evaluation and management of peripartum cardiomyopathy. J Emerg Med. 2009. 36:141–147.

30. Moioli M, Valenzano Menada M, Bentivoglio G, Ferrero S. Peripartum cardiomyopathy. Arch Gynecol Obstet. 2010. 281:183–188.

31. Ramaraj R, Sorrell VL. Peripartum cardiomyopathy: Causes, diagnosis, and treatment. Cleve Clin J Med. 2009. 76:289–296.

32. Brar SS, Khan SS, Sandhu GK, Jorgensen MB, Parikh N, Hsu JW, et al. Incidence, mortality, and racial differences in peripartum cardiomyopathy. Am J Cardiol. 2007. 100:302–304.

33. Hilfiker-Kleiner D, Sliwa K, Drexler H. Peripartum cardiomyopathy: recent insight in its pathophysiology. Trends Cardiovasc Med. 2008. 18:173–179.

34. Lamparter S, Pankuweit S, Maisch B. Clinical and immunologic characteristics in peripartum cardiomyopathy. Int J Cardiol. 2007. 118:14–20.

35. Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, et al. Underlying causes and long term survival in patients with initially unexplained cardiomyopathy. N Engl J Med. 2000. 342:1077–1084.

36. Sliwa K, Skudicky D, Bergemann A, Candy G, Puren A, Sareli P. Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/Apo-1. J Am Coll Cardiol. 2000. 35:701–705.

37. Ro A, Frishman WH. Peripartum cardiomyopathy. Cardiol Rev. 2006. 14:35–42.

38. Burch GE, McDonald CD, Walsh JJ. The effect of prolonged bed rest on postpartal cardiomyopathy. Am Heart J. 1971. 81:186–201.

39. McIndoe AK, Hammond EJ, Babington PC. Peripartum cardiomyopathy presenting as a cardiac arrest at induction of anesthesia for emergency cesarean section. Br J Anaesth. 1995. 75:97–101.

40. Shaikh N. An obstetric emergency called peripartum cardiomyopathy! J Emerg Trauma Shock. 2010. 3:39–42.

41. Malinow AM, Butterworth JF 4th, Johnson MD, Safon L, Rein M, Hartwell B, et al. Peripartum cardiomyopathy presenting at cesarean delivery. Anesthesiology. 1985. 63:545–547.

42. Shnaider R, Ezri T, Szmuk P, Larson S, Warters RD, Katz J. Combined spinal-epidural anesthesia for Cesarean section in a patient with peripartum dilated cardiomyopathy. Can J Anaesth. 2001. 48:681–683.

43. Benezet-Mazuecos J, de la Hera J. Peripartum cardiomyopathy: a new successful setting for levosimendan. Int J Cardiol. 2008. 123:346–347.

44. Melvin KR, Richardson PJ, Olsen EG, Daly K, Jackson G. Peripartum cardiomyopathy due to myocarditis. N Engl J Med. 1982. 307:731–734.

45. Bilehjani E, Kianfar AA, Toofan M, Fakhari S. Anaesthesia with etomidate and remifentanil for cesarean section in a patient with severe peripartum cardiomyopathy--a case report. Middle East J Anesthesiol. 2008. 19:1141–1149.

46. Meyer GP, Labidi S, Podewski E, Sliwa K, Drexler H, Hilfiker-Kleiner D. Bromocriptine treatment associated with recovery from peripartum cardiomyopathy in siblings: two case reports. J Med Case Reports. 2010. 4:80.

47. Reuwer AQ, Reuwer PJ, van der Post JA, Cramer MJ, Kastelein JJ, Twickler MT. Prolactin fragmentation by trophoblastic matrix metalloproteinases as a possible contributor to peripartum cardiomyopathy and pre-eclampsia. Med Hypotheses. 2010. 74:348–352.

48. Hilfiker-Kleiner D, Kaminski K, Podewski E, Bonda T, Schaefer A, Sliwa K, et al. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell. 2007. 128:589–600.

49. Forster O, Hilfiker-Kleiner D, Ansari AA, Sundstrom JB, Libhaber E, Tshani W, et al. Reversal of IFN-gamma, oxLDL and prolactin serum levels correlate with clinical improvement in patients with peripartum cardiomyopathy. Eur J Heart Fail. 2008. 10:861–868.

50. Hayakawa Y, Chandra M, Miao W, Shirani J, Brown JH, Dorn GW 2nd, et al. Inhibition of cardiac myocyte apoptosis improves cardiac function and abolishes mortality in the peripartum cardiomyopathy of Galpha(q) transgenic mice. Circulation. 2003. 108:3036–3041.

51. Fett JD. Understanding peripartum cardiomyopathy, 2008. Int J Cardiol. 2008. 130:1–2.

52. de Jong JS, Rietveld K, van Lochem LT, Bouma BJ. Rapid left ventricular recovery after cabergoline treatment in a patient with peripartum cardiomyopathy. Eur J Heart Fail. 2009. 11:220–222.

53. Mouquet F, Lions C, de Groote P, Bouabdallaoui N, Willoteaux S, Dagorn J, et al. Characterisation of peripartum cardiomyopathy by cardiac magnetic resonance imaging. Eur Radiol. 2008. 18:2765–2769.

54. Marmursztejn J, Vignaux O, Goffinet F, Cabanes L, Duboc D. Delayed-enhanced cardiac magnetic resonance imaging features in peripartum cardiomyopathy. Int J Cardiol. 2009. 137:e63–e64.

55. Page RL. Treatment of arrhythmias during pregnancy. Am Heart J. 1995. 130:871–876.

56. Bozkurt B, Villaneuva FS, Holubkov R, Tokarczyk T, Alvarez RJ Jr, MacGowan GA, et al. Intravenous immune globulin in the therapy of peripartum cardiomyopathy. J Am Coll Cardiol. 1999. 34:177–180.

57. George LM, Gatt SP, Lowe S. Peripartum cardiomyopathy: four case histories and a commentary on anaesthetic management. Anaesth Intensive Care. 1997. 25:292–296.

58. Hopp L, Weisse AB, Iffy L. Acute myocardial infarction in a healthy mother using bromocriptine for milk suppression. Can J Cardiol. 1996. 12:415–418.

59. Zimmerman H, Bose R, Smith R, Copeland JG. Treatment of peripartum cardiomyopathy with mechanical assist devices and cardiac transplantation. Ann Thorac Surg. 2010. 89:1211–1217.

60. Smith IJ, Gillham MJ. Fulminant peripartum cardiomyopathy rescue with extracorporeal membranous oxygenation. Int J Obstet Anesth. 2009. 18:186–188.

61. Okutomi T, Saito M, Amano K, Fukuoka K, Hoka S. Labour analgesia guided by echocardiography in a parturient with primary dilated cardiomyopathy. Can J Anaesth. 2005. 52:622–625.

62. Gambling DR, Flanagan ML, Huckell VF, Lucas SB, Kim JH. Anaesthetic management and non-invasive monitoring for caesarean section in a patient with cardiomyopathy. Can J Anaesth. 1987. 34:505–508.

63. Sutton MS, Cole P, Plappert M, Saltzman D, Goldhaber S. Effects of subsequent pregnancy on left ventricular function in peripartum cardiomyopathy. Am Heart J. 1991. 121:1776–1778.

64. Fett JD, Christie LG, Carraway RD, Murphy JG. Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo Clin Proc. 2005. 80:1602–1606.

65. Cénac A, Tourmen Y, Adehossi E, Couchouron N, Djibo A, Abgrall JF. The duo low plasma NT-PRO-BRAIN natriuretic peptide and C-reactive protein indicates a complete remission of peripartum cardiomyopathy. Int J Cardiol. 2006. 108:269–270.

66. Fett JD, Fristoe KL, Welsh SN. Risk of heart failure relapse in subsequent pregnancy among peripartum cardiomyopathy mothers. Int J Gynaecol Obstet. 2010. 109:34–36.

67. Dorbala S, Brozena S, Zeb S, Galatro K, Homel P, Ren JF, et al. Risk stratification of women with peripartum cardiomyopathy at initial presentation: a dobutamine stress echocardiography study. J Am Soc Echocardiogr. 2005. 18:45–48.

68. Williams KP, Galerneau F. The role of serum uric acid as a prognostic indicator of the severity of maternal and fetal complication in hypertensive pregnancies. J Obstet Gynaecol Can. 2002. 24:628–632.

69. Horlocker TT, Wedel DJ, Rowlingson JC, Enneking FK, Kopp SL, Benzon HT, et al. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition). Reg Anesth Pain Med. 2010. 35:64–101.

70. Braga Ade F, Braga FS, Poterio GM, Pereira RI, Reis E, Cremonesi E. Sufentanil added to hyperbaric bupivacaine for subarachnoid block in Caesarean section. Eur J Anaesthesiol. 2003. 20:631–635.

71. Bachmann-Mennenga B, Veit G, Steinicke B, Biscoping J, Heesen M. Efficacy of sufentanil addition to ropivacaine epidural anaesthesia for Caesarean section. Acta Anaesthesiol Scand. 2005. 49:532–537.